Angiotensin II and Superoxide Generation

Author(s):  
Sergey I. Dikalov ◽  
David G. Harrison
2009 ◽  
Vol 153 (1-3) ◽  
pp. 1-6 ◽  
Author(s):  
A.E. Hirata ◽  
D. Morgan ◽  
H.R. Oliveira-Emilio ◽  
M.S. Rocha ◽  
C.R.O. Carvalho ◽  
...  

2008 ◽  
Vol 294 (2) ◽  
pp. C413-C422 ◽  
Author(s):  
Craig Ricci ◽  
Viktor Pastukh ◽  
Josh Leonard ◽  
Julio Turrens ◽  
Glenn Wilson ◽  
...  

Recently, it has become apparent that mitochondrial DNA (mtDNA) damage can rapidly initiate apoptosis independent of mutations, although the mechanism involved remains unclear. To elucidate this mechanism, angiotensin II-mediated apoptosis was studied in cells that were transduced with a lentiviral vector to overexpress the DNA repair enzyme 8-oxoguanine glycosylase or were treated with inhibitors known to block angiotensin II-induced mtDNA damage. Cells exhibiting angiotensin II-induced mtDNA damage showed two phases of superoxide generation, the first derived from NAD(P)H oxidase and the second of mitochondrial origin, whereas cells prevented from experiencing mtDNA damage importantly exhibited only the first phase. Furthermore, cells with mtDNA damage demonstrated impairments in mitochondrial protein expression, cellular respiration, and complex 1 activity before the onset of the second phase of oxidation. After the second phase, the mitochondrial membrane potential collapsed, cytochrome c was released, and the cells underwent apoptosis, all of which were prevented by disrupting mtDNA damage. Collectively, these data reveal a novel mechanism of apoptosis that is initiated when mtDNA damage triggers mitochondrial superoxide generation and ultimately the activation of the mitochondrial permeability transition. This novel mechanism may play an important pathological role.


Hypertension ◽  
1998 ◽  
Vol 32 (2) ◽  
pp. 331-337 ◽  
Author(s):  
Patrick J. Pagano ◽  
Stephen J. Chanock ◽  
Deborah A. Siwik ◽  
Wilson S. Colucci ◽  
Justin K. Clark

2007 ◽  
Vol 292 (6) ◽  
pp. H2997-H3005 ◽  
Author(s):  
Lili Ding ◽  
Alexander Chapman ◽  
Ryan Boyd ◽  
Hui Di Wang

Arteries from hypertensive animals and humans have increased spontaneous tone. Increased superoxide anion (superoxide) contributes to elevated blood pressure (BP) and spontaneous tone in hypertension. The association between the extracellular signaling-regulated kinase 1/2 (ERK1/2)-mitogen-activated protein kinase (MAPK) signaling pathway and generation of superoxide and spontaneous tone in isolated aorta was studied in angiotensin II (ANG II)-infused hypertensive (HT) rats. Systolic BP, phosphorylation of ERK, aortic superoxide formation, and aortic spontaneous tone were compared in sham normotensive and HT rats. Infusion of ANG II (0.5 mg·kg−1·day−1 for 6 days) significantly elevated the systolic BP ( P < 0.01). The phosphorylation of ERK1/2 vs. total ERK1/2 in thoracic aorta was enhanced, and superoxide was increased in the HT vs. the sham group ( P < 0.01). Spontaneous tone developed in the HT group, but not in the normotensive group. MAPK/ERK1/2 (MEK1/2)-ERK1/2 signaling pathway inhibitors, PD-98059 (10 μmol/l), and U-0126 (10 μmol/l), significantly reduced the phosphorylation of ERK1/2, superoxide generation ( P < 0.01), and spontaneous tone ( P < 0.01) in HT. These findings suggest that ANG II infusion induces the production of superoxide and spontaneous tone and that both are dependent on ERK-MAPK activation. In endothelium-denuded aorta, however, MEK1/2 inhibitors did not inhibit the spontaneous tone, even though they significantly reduced superoxide generation similar to endothelium-intact aorta. These data suggest that inhibition of ERK1/2 signaling pathway, via PD-98059 or U-0126, may regulate spontaneous tone in an endothelium-dependent manner. In conclusion, these findings support the importance of the ERK1/2 signaling pathway in modulating vascular oxidative stress and subsequently mediating spontaneous tone in HT.


Sign in / Sign up

Export Citation Format

Share Document